| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.622 | 6.698 | 247 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 3.622 | 6.698 | 247 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 3.119 | 6.210 | 282 | 121 | 160 | 18 | 25 | 206 | 0 | 0 |
| Gross Profit/Loss - EUR | 503 | 488 | -35 | -121 | -160 | -18 | -25 | -206 | 0 | 0 |
| Net Profit/Loss - EUR | 395 | 287 | -42 | -121 | -160 | -18 | -25 | -206 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Miltiadis Farmas Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 138 | 137 | 134 | 132 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 2.153 | 1.356 | 1.259 | 1.291 | 1.235 | 1.193 | 680 | 476 | 474 | 471 |
| Inventories | 1.816 | 374 | 204 | 200 | 197 | 193 | 189 | 0 | 0 | 0 |
| Receivables | 246 | 452 | 444 | 507 | 503 | 497 | 491 | 476 | 474 | 471 |
| Cash | 91 | 530 | 610 | 583 | 535 | 503 | 0 | 0 | 0 | 0 |
| Shareholders Funds | -1.995 | -1.687 | -1.701 | -1.790 | -1.915 | -1.897 | -1.880 | -2.092 | -2.086 | -2.074 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.285 | 3.180 | 3.094 | 3.213 | 3.150 | 3.091 | 2.560 | 2.568 | 2.560 | 2.546 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "150 - 150" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Miltiadis Farmas Srl